79 results
·
31ms
·
Sources: EU EUDAMED, US FDA
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·May 12, 2009
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·September 11, 2009
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·August 30, 2010
HYALURONIC ACID (BRAND NAME NOT REPORTED)
FDA Adverse Event
Other
·UNK·Product code LMH·May 27, 2010
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·May 1, 2009
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·May 14, 2009
RESTYLANE INJECTABLE GEL
FDA Adverse Event
Other
·Q-MED AB·Product code LMH·June 10, 2009